FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Upcoming FDA Decisions February 2025 Guideline Central The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and 2025 FDA approvals: volume maintained, but value remains below average